About this trial
Brief Admission by self-referral (BA) is a standardized treatment model, providing patient-controlled and person-centered care. It was developed to reduce self-harm and compulsory care by promoting autonomy. Randomized clinical trials have not yielded significant between group differences with respect to inpatient care, including compulsory care. The major difficulty in evaluating BA is preventing the control group from cross-contamination, as in the implementation process of BA, all physicians, all inpatient and outpatient staff as well as managers need to be informed and undergo basic education regarding the intervention. As BA addresses a prevalent and frustrating issue in psychiatric health care, there is considerable risk that the approach leaks to the control group, reducing the possibility to detect between-group differences. In the current study this will be addressed through a register-based approach, comparing similar clinics, implementing BA at different timepoints over time. Individuals with traits of borderline personality disorder will be included and comparisons will be made with respect to compulsory care, voluntary inpatient care and mortality.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Living in the uptake area of Lund, Linköping, Helsingborg or Norrköping
Age 18-65 years at the time of inclusion
Admitted to hospital either diagnosed with ICD-10 diagnosis BPD F60.3, or admitted at least twice with Intentional self-harm X60-83 in combination with one of more of the following diagnoses ADHD (F90.0-F90.X), Bipolar disorder type 2, (F31.8W, F318A-F, F31.0, F31.8-9, F31.8W) or Autism, Atypical autism, Aspergers syndrome (F84.0, F84.1, F84.5) or Mild intellectual disability (F70.0-F70.9).
Disqualifiers
not fulfilling inclusion criteria
Trial population
Individuals with repeated self-harm and traits of Borderline personality disorder
Trial design
Other
Other
Treatments tested in this trial
Brief Admission by self-referral (BA)
Other interventionThrough means of an individualised contract access to self-referral to inpatient treatment limited to a maximum of three nights, three times per month.
Treatment groups
12
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Days with compulsory admission
Days with compulsory admission (days/year)
Secondary outcomes
Days with voluntary psychiatric admission
Days with voluntary psychiatric admission (days/year)
Duration of free intervals between admissions
Duration of free intervals between admissions (days)
Mortality
All cause mortality as well as death by suicide specifically (X60-X84 and Y10-Y34 in ICD10)
Number of compulsory admissions
Number of compulsory admissions (admissions/year)
Other outcomes
Gender distribution
Differences in distribution of diagnoses between men and women
Number of admissions with Brief admission by self-referral (BA)
Number of BA admissions (admissions/year)
Compulsory admission - median length
Compulsory admission - median length (days/admission)
Voluntary psychiatric admissions - median length
Voluntary psychiatric admissions - median length (days/admission)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.